From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Pardonnez moi je parle le Francais pour Jean Marc. Il est un grenouille qui achete merde

By Tom Winnifrith | Wednesday 11 August 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Maybe I have got my Franglais a bit wrong but I do my best as I explain why Jean Marc just does not get it with Braveheart (BRH) and the spiv Trevor Brown. I start with a few more words on why I hate the Greek seaside which the Mrs forces me to go to and which has put me in a foul mood as a result. It always does as I noted a few weeks ago. I then look at the ramptastic disaster that is Helium One (HE1) and then, mentioning today’s Pello expose, I go onto a detailed analysis of the position at the fraud Zoetic (ZOE) and why the shares, now down to 39.25p, are heading to between 0p and 5p.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 18:03:54